Advertisement
Advertisement

CRBU

CRBU logo

Caribou Biosciences, Inc. Common Stock

1.94
USD
Sponsored
+0.06
+3.19%
May 08, 15:59 UTC -4
Closed
exchange

After-Market

1.94

0.00
-0.05%

Caribou Biosciences, Inc. Common Stock Profile

About

Caribou Biosciences Inc. is a clinical-stage CRISPR genome-editing biopharmaceutical company. It involved in developing a pipeline of genome-edited, off-the-shelf CAR-T and CAR-NK cell therapies for the treatment of both hematologic malignancies and solid tumors. Caribou Biosciences Inc. is based in BERKELEY, Calif.

Info & Links

CEO

Rachel E. Haurwitz

Headquarters

2929 7TH STREET, SUITE 105
BERKELEY, CA 94710, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.cariboubio.com

Auditor

Deloitte & Touche LLP

Share holders

34

Employees

97

Caribou Biosciences, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

190.52M

Enterprise Value

178.47M

Enterprise Value/EBITDA(ttm)

-1.38

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

16.97

Price to Book(mrq)

1.50

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-1137.04%

Profit Margin(ttm)

-1413.36%

Return on Equity(ttm)

-78.40%

Return on Invested Capital(ttm)

-92.08%

Return on Assets(ttm)

-58.68%

Income Statement

Revenue(ttm)

11.20M

Revenue Per Share(ttm)

0.11

Gross Profit(ttm)

11.20M

EBITDA(ttm)3

-129.54M

Net Income Available to Common(ttm)

-133.22M

Diluted EPS(ttm)

-1.59

Share Statistics

Beta (5Y Monthly)

2.46

52-Week Change

145.57%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

99.18M

Dividend Yield

0.00%

Float4

88.64M

% Held by Insiders

8.28%

% Held by Institutions

77.51%

Balance Sheet

Total Cash(mrq)

117.63M

Total Cash Per Share(mrq)

1.19

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

5.71%

Quick Ratio(mrq)

5.71%

Book Value Per Share(mrq)

1.28

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.19

Free Cash Flow(ytd)

-112.35M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement